EHA 2024: Transforming Insights into Action for Better Patient Outcomes
As we reflect on EHA 2024, the impact of this year’s congress continues to resonate within the hematology community. The groundbreaking research, innovative treatment strategies, and expert discussions presented at…
EHA 2024: Bridging Research and Practice to Elevate Hematology Care
From clinical trials to real-world applications, the EHA Congress has bridged the gap between research and practice, enhancing the standard of care for hematological patients. #EHA2024 #BridgingTheGap
A Doctor’s Battle Against Cancer: A Story of Hope and Innovation
An extraordinary story that shines a light on the remarkable advances in cancer treatment and the power of innovative research.Professor Richard Scolyer, co-director of the Melanoma Institute Australia, was faced…
Research Team from Beijing Chaoyang Hospital Unveils a New Mechanism Linking Double-Negative T Cells to Fatty Liver Disease Progression
A research team led by Dr. Dong Zhang and Dr. Guangyong Sun from Beijing Chaoyang Hospital, Capital Medical University, in collaboration with Dr. Zhongtao Zhang from Beijing Friendship Hospital, Capital…
BOC/BOA 2024 | Dr. Zhitao Ying: Annual Advances in Chinese Clinical Oncology 2023——B-Cell Lymphoma, T and NK Cell Lymphomas
Since 2015, the Chinese Society of Clinical Oncology (CSCO) has been dedicated to presenting annual reports on the progress of clinical oncology in China, under the theme "International Standards, Chinese Characteristics, Learning and Innovation." At the recent "2024 Annual Progress in Chinese Clinical Oncology Conference (BOC) and Best of ASCO 2024 China," the latest "Annual Advances in Chinese Clinical Oncology 2023" report was officially released. At this conference, Dr. Zhitao Ying from the Cancer Institute & Hospital Chinese Academy of Medical Sciences presented a detailed report on the advancements in lymphoma research in China for 2023.
Today, we join the global community in recognizing World Hepatitis Day
Today, we join the global community in recognizing World Hepatitis Day. This year’s theme, "Eliminate Hepatitis · Take Action Positively," underscores the importance of proactive measures in combating this liver…
Professor Michael Heneghan: Advancing Autoimmune Hepatitis Research
Autoimmune hepatitis (AIH) presents ongoing challenges in diagnosis and treatment, requiring continuous research to improve patient outcomes. Professor Michael A. Heneghan has been a leading voice in AIH research, providing…
2024 CACA Integrated Breast Cancer Conference | Unified Efforts for Comprehensive Care: Multidisciplinary Experts Discuss Breast Cancer Management
The Chinese Anti-Cancer Association, adhering to the tenet of "prevention, screening, diagnosis, treatment, and rehabilitation," has launched the "Chinese Tumor Integrated Diagnosis and Treatment Guidelines." At the 2024 CACA Integrated Breast Cancer Conference, "Oncology Frontier" invited three authoritative experts from internal medicine, surgery, and radiotherapy—Dr. Man Li from The Second Hospital of Dalian Medical University, Dr. Yingying Xu from The First Hospital of China Medical University, and Dr. Jiayi Chen from Ruijin Hospital, Shanghai JiaoTong University School of Medicine—to discuss the comprehensive management of breast cancer patients under the theme of "Integration for Prevention, Screening, Diagnosis, Treatment, and Rehabilitation." Under the moderation of Dr. Wei Li from Jiangsu Province Hospital, the three experts explored key aspects of comprehensive breast cancer management from personalized treatment, multidisciplinary collaboration, minimally invasive techniques, to new advancements in radiotherapy, providing valuable practical experience and theoretical guidance for future breast cancer management.
BOC/BOA 2024 | Professor Chen Xun: Dual Immunotherapy Brings New First-Line Option for Advanced Liver Cancer
Editor's Note: China has a high incidence of liver cancer, with most patients being diagnosed at an advanced stage, losing the opportunity for surgical cure. Currently, the treatment for advanced…